Miahelsa Holdings Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Miahelsa Holdings Corporation's yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.9×Over the last 3 years its own operating cash covered its investment spending (capex) 2.9 times.
Higher than 73% of Healthcare companies in Japan.
Cash Locked Ratio
¥1For every ¥100 of sales, ¥1 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥1 tied up three years earlier.
Less money tied up than 80% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
−¥0Sales grew 12% in 3 years, but profit fell: ¥0 less profit per ¥100 of extra sales.
Lower than 69% of Healthcare companies in Japan.
Asset Productivity Ratio
+12% / +10%In 3 years sales changed by +12% while total assets changed by +10%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
0.2×Debt due within a year is covered 0.2 times by its yearly operating cash.
Lower than 71% of Healthcare companies in Japan.
Cash Cushion Ratio
−43%Debt, after subtracting cash, equals 43% of its market value (net debt).
Lower than 83% of Healthcare companies in Japan.
Tangible Assets Ratio
98%Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 55% of Healthcare companies in Japan.
Tangible Net Worth Ratio
91%Of every ¥100 of net worth, ¥91 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 57% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Miahelsa Holdings Corporation owes ¥0.75 for every ¥1 it owns. Net profit fell 33% in the year to Mar 2026, and shrank 1% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
17.6Investors pay ¥17.6 for every ¥1 of Miahelsa Holdings Corporation's yearly profit, higher than 57% of Healthcare companies in Japan.
P/B ratio
0.80The share price is 0.80 times Miahelsa Holdings Corporation's book value per share, lower than 85% of Healthcare companies in Japan.
Market cap
¥3.1 BThe total market value of all of Miahelsa Holdings Corporation's shares at today's price (share price × number of shares), smaller than 89% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥3.9 BWhat Miahelsa Holdings Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥1,397Net worth divided by the number of shares. The share price of ¥1,123 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
4.6%Miahelsa Holdings Corporation earned 4.6% on its shareholders' money over the last year, lower than 63% of Healthcare companies in Japan.
Owes vs Owns
0.75×Miahelsa Holdings Corporation owes ¥0.75 for every ¥1 it owns (moderate), higher than 89% of Healthcare companies in Japan.
Dividend yield
2.68%Miahelsa Holdings Corporation pays 2.68% of its share price as dividends a year, lower than 53% of dividend-paying Healthcare companies in Japan.
Revenue growth
+4%Revenue rose 4% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Profit growth
-33%Net profit fell 33% in the year to Mar 2026, and shrank 1% a year on average over 3 years.
Profit margin
0.8%Miahelsa Holdings Corporation keeps ¥1 of every ¥100 of revenue as net profit.
Cash quality
4.5×Cash from Miahelsa Holdings Corporation's business was 4.5× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
18.4×Miahelsa Holdings Corporation's operating profit covered its interest costs 18.4 times in the year to Mar 2026.
Cash vs debt
Net debtMiahelsa Holdings Corporation had ¥1.3 B more debt than cash (net debt) at Mar 2026.
Questions
What is Miahelsa Holdings Corporation's P/E ratio?
Investors pay ¥17.6 for every ¥1 of Miahelsa Holdings Corporation's yearly profit, higher than 57% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Miahelsa Holdings Corporation: ¥3.1 B ÷ ¥3.9 B (31 Mar 2026) = 0.8.
What is Miahelsa Holdings Corporation's return on equity?
Miahelsa Holdings Corporation earned 4.6% on its shareholders' money over the last year, lower than 63% of Healthcare companies in Japan.
How much does Miahelsa Holdings Corporation owe compared with what it owns?
Miahelsa Holdings Corporation owes ¥0.75 for every ¥1 it owns (moderate), higher than 89% of Healthcare companies in Japan.
Does Miahelsa Holdings Corporation pay a dividend?
Yes. Miahelsa Holdings Corporation pays 2.68% of its share price as dividends a year, lower than 53% of dividend-paying Healthcare companies in Japan.
Is Miahelsa Holdings Corporation's revenue growing?
Revenue rose 4% in the year to Mar 2026, and grew 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.